May 19, 2023: NCHR supports the proposed criteria for ranking antimicrobial new animal drugs according to their importance to human medicine; however these criteria need to be applied correctly. FDA should classify bacitracin as medically important and should almost always give antibiotics belonging to the same drug class the same rankings of medical importance.
Read More »Author: Caroline Bradford
NCHR Comments on the Filing of Color Additive Petition to FDA from the Center for Science in the Public Interest
May 18, 2023: We support the request that the FDA ban the use of FD&C Red No. 3 in foods, drugs, and dietary supplements. We find it unacceptable that the FDA has known for more than 30 years that Red 3 can cause cancer and yet still allows the dye to be used in foods, drugs, and supplements.
Read More »NCHR Comments on the FDA Filing of Color Additive Petition Concerning Red No. 3
May 18, 2023: NCHR strongly supports the petition from the Center for Science and the Public Interest urging an FDA ban on the use of FD&C Red No. 3 in foods, drugs, and dietary supplements. We find it unacceptable that the FDA has known for more than 30 years that Red 3 can cause cancer and yet still allows the dye to be used in these products.
Read More »NCHR Testimony at the FDA Advisory Committee Hearing on OTC Access to Norgestrel (OPill)
May 9, 2023: NCHR testified on the proposed first-in-class prescription-to-nonprescription switch of OPill (norgestrel) tablet, a progestin-only oral contraceptive pill (POP), and expressed concerns that the data demonstrated that a substantial minority of consumers did not understand written information about how to use the pill safely if they were not instructed by their physician.
Read More »Alzheimer’s drug donanemab: what promising trial means for treatments
Nature, May 4, 2023: Nature news article quotes Eli Lilly’s press release claiming donanemab delays cognitive decline from Alzheimer’s Disease, but we ask if the small benefit is meaningful to patients with mild cognitive impairment compared to the risk of death or brain swelling or bleeding.
Read More »